LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 8 of 87
Next
>>
>
176 to 200 of 2160 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Imatinib	0.04	uM	LJP6	2	N18	72	hr	1657	5810	5505	1.0553	1.0791
BT-20	Imatinib	0.04	uM	LJP6	3	N18	72	hr	1657	5135	5505	0.9327	0.9037
BT-20	JNK-9L	0.04	uM	LJP6	1	K24	72	hr	1657	4317	5505	0.7841	0.6911
BT-20	JNK-9L	0.04	uM	LJP6	2	K24	72	hr	1657	4838	5505	0.8787	0.8265
BT-20	JNK-9L	0.04	uM	LJP6	3	K24	72	hr	1657	4358	5505	0.7916	0.7017
BT-20	JW-7-24-1	0.04	uM	LJP6	1	B24	72	hr	1657	4605	5505	0.8364	0.7659
BT-20	JW-7-24-1	0.04	uM	LJP6	2	B24	72	hr	1657	5099	5505	0.9261	0.8943
BT-20	JW-7-24-1	0.04	uM	LJP6	3	B24	72	hr	1657	4607	5505	0.8368	0.7665
BT-20	Lapatinib	0.04	uM	LJP6	1	M24	72	hr	1657	4618	5505	0.8388	0.7693
BT-20	Lapatinib	0.04	uM	LJP6	2	M24	72	hr	1657	5335	5505	0.9690	0.9557
BT-20	Lapatinib	0.04	uM	LJP6	3	M24	72	hr	1657	5000	5505	0.9082	0.8686
BT-20	LDN-193189	0.04	uM	LJP5	1	G06	72	hr	1657	5327	5505	0.9676	0.9536
BT-20	LDN-193189	0.04	uM	LJP5	2	G06	72	hr	1657	5399	5505	0.9806	0.9723
BT-20	LDN-193189	0.04	uM	LJP5	3	G06	72	hr	1657	5479	5505	0.9952	0.9931
BT-20	Linifanib	0.04	uM	LJP6	1	J12	72	hr	1657	5914	5505	1.0742	1.1061
BT-20	Linifanib	0.04	uM	LJP6	2	J12	72	hr	1657	5912	5505	1.0738	1.1056
BT-20	Linifanib	0.04	uM	LJP6	3	J12	72	hr	1657	5838	5505	1.0604	1.0864
BT-20	Linsitinib	0.04	uM	LJP5	1	O24	72	hr	1657	4450	5505	0.8083	0.7257
BT-20	Linsitinib	0.04	uM	LJP5	2	O24	72	hr	1657	4917	5505	0.8931	0.8470
BT-20	Linsitinib	0.04	uM	LJP5	3	O24	72	hr	1657	4963	5505	0.9014	0.8590
BT-20	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1657	2532	5505	0.4599	0.2272
BT-20	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1657	2950	5505	0.5358	0.3358
BT-20	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1657	2967	5505	0.5389	0.3403
BT-20	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1657	2486	5505	0.4515	0.2153
BT-20	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1657	3076	5505	0.5587	0.3686

|<
<<
Previous
Page 8 of 87
Next
>>
>
176 to 200 of 2160 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)